Issue 1/2015
Content (22 Articles)
Guidelines are essential to improving clinical outcomes in breast cancer patients
Alberto J. Montero
Post-irradiation angiosarcoma of the breast: clinical presentation and outcome in a series of six cases
Anton Uryvaev, Mor Moskovitz, Roxolyana Abdach-Bortnyak, Dov Hershkovitz, Georgeta Fried
Localized experimental bone metastasis drives osteolysis and sensory hypersensitivity at distant non-tumor-bearing sites
Dareen M. Abdelaziz, Laura S. Stone, Svetlana V. Komarova
Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer
Parvin Forghani, Edmund K. Waller
Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer
Elin Karlsson, Cynthia Veenstra, Shad Emin, Chhanda Dutta, Gizeh Pérez-Tenorio, Bo Nordenskjöld, Tommy Fornander, Olle Stål
Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells
Prathap Kumar S. Mahalingaiah, Logeswari Ponnusamy, Kamaleshwar P. Singh
Heat shock factor 1 induces cancer stem cell phenotype in breast cancer cell lines
Bin Wang, Chung-Wei Lee, Abigail Witt, Ankita Thakkar, Tan A. Ince
Assessment of HER2 status in invasive breast cancers with increased centromere 17 copy number
Min Hye Jang, Eun Joo Kim, Hyun Jeong Kim, Yul Ri Chung, So Yeon Park
Proteasome inhibitors induce AMPK activation via CaMKKβ in human breast cancer cells
Rahul R. Deshmukh, Q. Ping Dou
Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density
G. L. Chew, C. W. Huo, D. Huang, P. Hill, J. Cawson, H. Frazer, J. L. Hopper, I. Haviv, M. A. Henderson, K. Britt, E. W. Thompson
Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis
Swapnil Ulhas Rane, Hasan Mirza, Anita Grigoriadis, Sarah E. Pinder
A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity
Xuejing Yao, Jing Jiang, Xin Wang, Changjiang Huang, Dong Li, Kuan Xie, Qiaoyu Xu, Hongwen Li, Zhuanglin Li, Liguang Lou, Jianmin Fang
Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy
Amadeo M. Parissenti, Baoqing Guo, Laura B. Pritzker, Kenneth P. H. Pritzker, Xiaohui Wang, Mu Zhu, Lois E. Shepherd, Maureen E. Trudeau
The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure
M. Jebbink, E. van Werkhoven, I. A. M. Mandjes, J. Wesseling, E. H. Lips, M.-J. T. D. F. Vrancken Peeters, C. E. Loo, G. S. Sonke, S. C. Linn, C. Falo Zamora, S. Rodenhuis
A proposal for a new classification of T4 breast cancer as stage IIIC: a report from the Korean Breast Cancer Society
Hee Jeong Kim, Hwa Jung Kim, Sae Byul Lee, Hyeong-Gon Moon, Woo Chul Noh, Young Up Cho, Youngbum Yoo, Sei Hyun Ahn
All eyes on the patient: the influence of oncologists’ nonverbal communication on breast cancer patients’ trust
Marij A. Hillen, Hanneke C. J. M. de Haes, Geertjan van Tienhoven, Nina Bijker, Hanneke W. M. van Laarhoven, Daniëlle M. Vermeulen, Ellen M. A. Smets
Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer
A. Jo Chien, Erin Duralde, Richard Hwang, Karen Tsung, Chia-Ning Kao, Hope S. Rugo, Michelle E. Melisko, Laura J. Esserman, Pamela N. Munster, Marcelle Cedars, Karla Kerlikowske, Charles E. McCulloch, Mitch P. Rosen
Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes
Robert W. Mutter, Marlene H. Frost, Tanya L. Hoskin, Joanne L. Johnson, Lynn C. Hartmann, Judy C. Boughey
Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing
Megan C. Roberts, Morris Weinberger, Stacie B. Dusetzina, Michaela A. Dinan, Katherine E. Reeder-Hayes, Melissa A. Troester, Lisa A. Carey, Stephanie B. Wheeler
Deleterious BRCA1/2 mutations in an urban population of Black women
Filipa Lynce, Karen Lisa Smith, Julie Stein, Tiffani DeMarco, Yiru Wang, Hongkun Wang, Melissa Fries, Beth N. Peshkin, Claudine Isaacs
Breast cancer survival in African-American women by hormone receptor subtypes
Tomi Akinyemiju, Justin Xavier Moore, Sean F. Altekruse
Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype
Kuo-Wang Tsai, Guan-Cheng Li, Chien-Hsun Chen, Ming-Hsin Yeh, Jer-Shyung Huang, Hui-Hwa Tseng, Ting-Ying Fu, Huei-Han Liou, Hung-Wei Pan, Sheng-Feng Huang, Chien-Chou Chen, Hui-Yu Chang, Luo-Ping Ger, Hong-Tai Chang